Skip to main content
. 2020 Jul 1;6(7):1208–1222. doi: 10.1021/acscentsci.9b01235

Figure 1.

Figure 1

Schematic illustration of PEG-sheddable nanodrug targeting M2-like TAMs for antitumor immunotherapy.